Back to Search Start Over

What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?

Authors :
Preusser M
Geurts M
Hainfellner JA
van den Bent MJ
Source :
Neuro-oncology [Neuro Oncol] 2023 Nov 02; Vol. 25 (11), pp. 1915-1917.
Publication Year :
2023

Details

Language :
English
ISSN :
1523-5866
Volume :
25
Issue :
11
Database :
MEDLINE
Journal :
Neuro-oncology
Publication Type :
Academic Journal
Accession number :
37477610
Full Text :
https://doi.org/10.1093/neuonc/noad113